Literature DB >> 21848581

Why people choose to not use complementary therapies during cancer treatment: a focus group study.

L Beatty1, B Koczwara, V Knott, T Wade.   

Abstract

While 50% of cancer patients use complementary therapies (CT) during treatment, few studies have examined why individuals choose not to use CT. This study aimed to address this gap in knowledge using a focus group methodology, where 36 participants took part in one of eight groups; participants were recruited until saturation of themes was achieved. Three categories of participants were investigated: patients/recent survivors (n= 14); volunteers/advocates (n= 16), the majority of whom were also long-term survivors; and health professionals (n= 6). Focus groups were digitally audio-recorded, transcribed, and coded thematically using NVivo software. Reasons for non-use fell into four broad themes: (1) Resource barriers, particularly the cost and lack of time; (2) fear and distrust, including the potential for drug interactions; (3) lack of evidence, including the unproven nature of many CT practices; and (4) satisfaction with conventional treatment. Two further themes related to the benefits of non-use and reasons for discontinuation. A sub-analysis indicated that reasons for non-use differed by CT category, with non-use being mentioned more frequently for biologically based and body-based therapies. Differences in understanding CT non-use emerged between patients, volunteers and health professionals. Findings have clinical implications regarding tailoring information for patients during and after cancer.
© 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Year:  2011        PMID: 21848581     DOI: 10.1111/j.1365-2354.2011.01279.x

Source DB:  PubMed          Journal:  Eur J Cancer Care (Engl)        ISSN: 0961-5423            Impact factor:   2.520


  3 in total

Review 1.  Integrating complementary medicine in supportive cancer care models across four continents.

Authors:  Eran Ben-Arye; Elad Schiff; Catherine Zollman; Peter Heusser; Pablo Mountford; Moshe Frenkel; Gil Bar-Sela; Ofer Lavie
Journal:  Med Oncol       Date:  2013-02-23       Impact factor: 3.064

2.  Guidance for establishing an integrative oncology service in the Australian healthcare setting-a discussion paper.

Authors:  Suzanne J Grant; Jennifer Hunter; Alan Bensoussan; Geoff P Delaney
Journal:  Support Care Cancer       Date:  2017-09-01       Impact factor: 3.603

3.  Australian integrative oncology services: a mixed-method study exploring the views of cancer survivors.

Authors:  Jennifer Hunter; Jane Ussher; Chloe Parton; Andrew Kellett; Caroline Smith; Geoff Delaney; Eleanor Oyston
Journal:  BMC Complement Altern Med       Date:  2018-05-09       Impact factor: 3.659

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.